Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02289 vs MCK, COR, CAH: FCF Margin % Comparison
For the Medical Distribution subindustry, Charmacy Pharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Charmacy Pharmaceutical Co FCF Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Charmacy Pharmaceutical Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Charmacy Pharmaceutical Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charmacy Pharmaceutical Co (HKSE:02289) has a FCF Margin % of 13.07% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Charmacy Pharmaceutical Co and its competitors. According to the industry distribution chart, Charmacy Pharmaceutical Co ranks #20 out of 117 companies in the Medical Distribution industry, placing it in the top 17.1%.
Is Charmacy Pharmaceutical Co's FCF Margin % too high?
Charmacy Pharmaceutical Co's current FCF Margin % is 13.07%. The Medical Distribution industry median FCF Margin % is 0.61. Charmacy Pharmaceutical Co's value of 13.07% is 2042.6% above this industry median. Based on the distribution chart, Charmacy Pharmaceutical Co ranks #20 out of 117 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Charmacy Pharmaceutical Co has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Charmacy Pharmaceutical Co's FCF Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Charmacy Pharmaceutical Co ranks #20 out of 117 companies for FCF Margin %. This places Charmacy Pharmaceutical Co in the top 17% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 0.61. Charmacy Pharmaceutical Co's value of 13.07% is 2042.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Distribution company?
The median FCF Margin % among Medical Distribution companies is 0.61, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Charmacy Pharmaceutical Co's current FCF Margin % of 13.07% is 2042.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Charmacy Pharmaceutical Co and its competitors. For the Medical Distribution industry, the median FCF Margin % is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Charmacy Pharmaceutical Co's current FCF Margin % is 13.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charmacy Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Charmacy Pharmaceutical Co (HKSE:02289) is currently considered Possible Value Trap. The stock's GF Value™ is HK$8.38, compared to a current price of HK$5.50 — trading 34.4% below its estimated fair value. The current FCF Margin % is 13.07% and 2042.6% above the Medical Distribution industry median of 0.61. Charmacy Pharmaceutical Co's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Charmacy Pharmaceutical Co (HKSE:02289), the current FCF Margin % is 13.07% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Charmacy Pharmaceutical Co (HKSE:02289) Overvalued in 2026?
Based on GuruFocus' analysis, Charmacy Pharmaceutical Co stock appears to be undervalued.
The current stock price of HK$5.50 is trading 34.4% below its estimated GF Value™ of HK$8.38.
GuruFocus considers Charmacy Pharmaceutical Co to be Possible Value Trap.
Key valuation signals for HKSE:02289:
FCF Margin %: 13.07%
GF Value™: HK$8.38 vs. price of HK$5.50 (34.4% below fair value)
Industry Position: 2042.6% above the Medical Distribution median (#20 of 117)
No single metric tells the full story. See the HKSE:02289 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Charmacy Pharmaceutical Co Ltd operates within the pharmaceutical distribution industry, with a primary focus on the distribution of pharmaceutical products. The principal business activities encompass the wholesale of pharmaceuticals and related services, along with road transportation and cargo warehousing. The company's distribution network covers Southern China and surrounding areas including Fujian province. All the group's operations are located in China.
76GF Score
Get the complete analysis for HKSE:02289
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02289 has been successfully added to your 
